TVTX icon

Travere Therapeutics

126 hedge funds and large institutions have $1.09B invested in Travere Therapeutics in 2015 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
+45
Holders Change %
+55.56%
% of All Funds
3.4%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.22%
New
53
Increased
40
Reduced
26
Closed
8
Calls
$45.5M
Puts
$6.75M
Net Calls
+$38.8M
Net Calls Change
-$2.88M
Name Holding Trade Value Shares
Change
Shares
Change %
Manulife (Manufacturers Life Insurance)
126
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$735 +$256 +7,721 +53%
QF
127
QVT Financial
New York
-$7.4M -308,989 Closed
DM
128
Deerfield Management
New York
-$3.79M -158,223 Closed
AA
129
AQR Arbitrage
Connecticut
-$3.58M -149,500 Closed
VAM
130
Visium Asset Management
New York
-$3.3M -137,696 Closed
Alyeska Investment Group
131
Alyeska Investment Group
Illinois
-$3M -125,000 Closed
SFM
132
Sphera Funds Management
Israel
-$2.67M -111,392 Closed
MIM
133
Monashee Investment Management
Massachusetts
-$1.2M -50,000 Closed
LP
134
LMR Partners
United Kingdom
-$287K -11,997 Closed